Pancreatic regeneration after ethionine-induced acute pancreatitis in rats lacking pancreatic CCK-A receptor gene expression. 2003

Takaya Sato, and Junichi Niikawa, and Ichiro Usui, and Tsunao Imamura, and Hitoshi Yoshida, and Shigeki Tanaka, and Keiji Mitamura
Second Department of Internal Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.

BACKGROUND We examined the effects of cholecystokinin (CCK) on the development of ethionine-induced pancreatitis and pancreatic recovery. We used Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model lacking pancreatic CCK-A receptor gene expression. METHODS Ethionine-induced pancreatitis was induced in the 7-week-old male OLETF rats and in a control group that does not lack the pancreatic CCK-A receptor, Long-Evans Tokushima Otsuka (LETO) rats. The two groups were maintained on a low-protein diet for 11 days. During the last 4 days of the low-protein diet, dl-ethionine 20 mg/100 g body weight was administered intraperitoneally once daily. Histologic and biochemical examinations of the pancreas were performed, and plasma CCK concentrations were measured on days 1, 4, and 7 after the last ethionine administration. RESULTS Pancreatic histologic scores for inflammation, hemorrhage, and necrosis in the LETO and OLETF rats were highest on days 1 and 4, respectively. Pancreatic weight, DNA content, and protein level per DNA content in both groups decreased during the low-protein diet, and recovery signs were delayed in the OLETF rats. The highest plasma CCK concentrations in the LETO and OLETF rats were reached on days 1 and 4, respectively. CONCLUSIONS Ethionine-induced pancreatitis developed in the OLETF rats, and their pancreatic regeneration was delayed in comparison to that in the LETO rats. Our results suggested that CCK plays an important role in the development of pancreatitis as well as in the pancreatic repair process.

UI MeSH Term Description Entries
D008297 Male Males
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011949 Receptors, Cholecystokinin Cell surface proteins that bind cholecystokinin (CCK) with high affinity and trigger intracellular changes influencing the behavior of cells. Cholecystokinin receptors are activated by GASTRIN as well as by CCK-4; CCK-8; and CCK-33. Activation of these receptors evokes secretion of AMYLASE by pancreatic acinar cells, acid and PEPSIN by stomach mucosal cells, and contraction of the PYLORUS and GALLBLADDER. The role of the widespread CCK receptors in the central nervous system is not well understood. CCK Receptors,Caerulein Receptors,Cholecystokinin Octapeptide Receptors,Cholecystokinin Receptors,Pancreozymin Receptors,Receptors, CCK,Receptors, Caerulein,Receptors, Pancreozymin,Receptors, Sincalide,Sincalide Receptors,CCK Receptor,CCK-4 Receptors,CCK-8 Receptors,Cholecystokinin Receptor,Receptors, CCK-4,Receptors, CCK-8,Receptors, Cholecystokinin Octapeptide,CCK 4 Receptors,CCK 8 Receptors,Octapeptide Receptors, Cholecystokinin,Receptor, CCK,Receptor, Cholecystokinin,Receptors, CCK 4,Receptors, CCK 8
D012038 Regeneration The physiological renewal, repair, or replacement of tissue. Endogenous Regeneration,Regeneration, Endogenous,Regenerations
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005001 Ethionine 2-Amino-4-(ethylthio)butyric acid. An antimetabolite and methionine antagonist that interferes with amino acid incorporation into proteins and with cellular ATP utilization. It also produces liver neoplasms.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

Takaya Sato, and Junichi Niikawa, and Ichiro Usui, and Tsunao Imamura, and Hitoshi Yoshida, and Shigeki Tanaka, and Keiji Mitamura
March 1998, Pancreas,
Takaya Sato, and Junichi Niikawa, and Ichiro Usui, and Tsunao Imamura, and Hitoshi Yoshida, and Shigeki Tanaka, and Keiji Mitamura
May 1997, Pancreas,
Takaya Sato, and Junichi Niikawa, and Ichiro Usui, and Tsunao Imamura, and Hitoshi Yoshida, and Shigeki Tanaka, and Keiji Mitamura
March 1998, Pancreas,
Takaya Sato, and Junichi Niikawa, and Ichiro Usui, and Tsunao Imamura, and Hitoshi Yoshida, and Shigeki Tanaka, and Keiji Mitamura
May 2003, Pancreas,
Takaya Sato, and Junichi Niikawa, and Ichiro Usui, and Tsunao Imamura, and Hitoshi Yoshida, and Shigeki Tanaka, and Keiji Mitamura
January 2003, Journal of gastroenterology,
Takaya Sato, and Junichi Niikawa, and Ichiro Usui, and Tsunao Imamura, and Hitoshi Yoshida, and Shigeki Tanaka, and Keiji Mitamura
July 2004, European journal of clinical investigation,
Takaya Sato, and Junichi Niikawa, and Ichiro Usui, and Tsunao Imamura, and Hitoshi Yoshida, and Shigeki Tanaka, and Keiji Mitamura
January 2007, Neuroimmunomodulation,
Takaya Sato, and Junichi Niikawa, and Ichiro Usui, and Tsunao Imamura, and Hitoshi Yoshida, and Shigeki Tanaka, and Keiji Mitamura
February 1954, Gastroenterology,
Takaya Sato, and Junichi Niikawa, and Ichiro Usui, and Tsunao Imamura, and Hitoshi Yoshida, and Shigeki Tanaka, and Keiji Mitamura
November 2004, American journal of surgery,
Takaya Sato, and Junichi Niikawa, and Ichiro Usui, and Tsunao Imamura, and Hitoshi Yoshida, and Shigeki Tanaka, and Keiji Mitamura
August 1995, Journal of gastroenterology,
Copied contents to your clipboard!